REBEKAH LEWIS: Open Payments
NPI 1386987717 · SAHUARITA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 12 payments from 8 companies in 2025. Trend: 2023 $173 · 2024 $250 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $75 |
| Amgen Inc. | 2 | $31 |
| Bioventus LLC | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Globus Medical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Smith+Nephew, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, SHINGRIX, SUPARTZ FX SODIUM HYALURONATE, REXULTI, BREZTRI, Senza, OTEZLA, KISUNLA.
Industry payments across AZ — which companies pay providers there.
